Brochure
23 Aug 2024

Biosimilars Pipeline

JPG 1.3 MB
Download

CuraTeQ Biologics is a biopharmaceutical company based in Hyderabad, India. We have a pipeline of 14 biosimilars of which: 3 products are filed with EMA, one product is filed with MHRA, and 4 products are in global Ph3 clinical trials. Dazublys™, our Trastuzumab biosimilar has received marketing authorization approval in India, and is also filed with EMA.

Content provided by our supplier

CuraTeQ Biologics

  • IN
  • 2024
    On CPHI since
  • 250 - 499
    Employees
Company types
Biopharmaceutical company
CMO/CDMO
Generics/Biosimilars Manufacturer
Pharmaceutical company
Primary activities
Biopharmaceutical
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Generic APIs producer
Pharmaceutical Company (generic finished products)
View company profile

Other Content from CuraTeQ Biologics ()